Cineverse Corp. (CNVS)
Cineverse Corp. (CNVS)
| Cash Flow | 2026-03-31 |
|---|---|
| Net (loss) income | -8,657 |
| Depreciation and amortization | 5,972 |
| Gain on bargain purchase | 4,250 |
| Stock-based compensation | 2,987 |
| Capitalized content | 2,625 |
| Acquisition-related income tax benefit | -2,629 |
| Fair value adjustment of deferred consideration | 950 |
| Amortization of debt issuance costs | 376 |
| Non-cash interest (income) expense | 375 |
| Allowance for content advances | 685 |
| Barter transactions | -30 |
| Other | -326 |
| Accounts receivable | 7,743 |
| Content advances | -5,618 |
| Other current and long-term assets | -524 |
| Accounts payable, accrued expenses, and other liabilities | -6,392 |
| Deferred revenue | -58 |
| Net cash (used in) provided by operating activities | -26,497 |
| Purchase of business, net of cash acquired | 9,967 |
| Expenditures for long-lived assets | 3,948 |
| Internally developed software capitalization | -405 |
| Sale of equity investment securities | 0 |
| Net cash used in investing activities | -14,320 |
| Proceeds from line of credit | 62,060 |
| Payments on line of credit | 52,625 |
| Proceeds from issuance of convertible notes | 13,000 |
| Proceeds from common stock warrant exercise | 5,842 |
| Proceeds from issuance of common stock for public offering | 3,450 |
| Proceeds from atm equity issuance, net of fees | 1,018 |
| Withholding taxes paid on restricted stock units | 965 |
| Debt and equity financing fees | 811 |
| Payment of deferred consideration | 559 |
| Payment of earnout consideration | 0 |
| Proceeds from the issuance of a term loan, net of debt issuance costs | 0 |
| Repayment of term loan | 0 |
| Cost to acquire treasury shares | 0 |
| Distribution paid on behalf of non-controlling interest | 170 |
| Net cash provided by (used in) financing activities | 30,240 |
| Net change in cash and cash equivalents | -10,577 |
| Effect of exchange rate changes on cash and cash equivalents | 23 |
| Cash and cash equivalents at beginning of period | 13,941 |
| Cash and cash equivalents at end of period | 3,387 |